Tofacitinib 477600-75-2 Tasocitinib 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile CP-690550 CP 690550 Cp-690 free base tofacitinibum 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile CP690550 87LA6FU830 CP-690550 FREE BASE CP-690,550 FREE BASE CP690,550 CP-690-550 CHEBI:71200 DTXSID90197271 CP-690 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-d)pyrimidin-4-yl-, (3R,4R)- 3-((3R,4R)-4-methyl-3-(methyl((7H-pyrrolo(2,3-d)pyrimidin-4-yl))amino)piperidin-1-yl)-3-oxopropanenitrile RefChem:6313 JAK inhibitors: tofacitinib DTXCID00119762 L04AA29 689-145-4 1259404-17-5 Tofacitinib (CP-690550,Tasocitinib) 3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile rac-Tofacitinib Tofacitinib [USAN] C16H20N6O CHEMBL221959 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-, (3R,4R)- racemic-tofacitinib racemic-Tasocitinib MFCD22628813 Tofacitinib (USAN) MFCD11035919 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanenitrile 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile (+)-TOFACITINIB Tofacitinib [USAN:INN] UNII-87LA6FU830 Tofacitinib? Tofacitinib (CP-690550) Tofacitinib Base 3eyg 3fup 3lxk 4oti 3-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile MI1 477600-75-2 (free base) Tofacitinib (Standard) TOFACITINIB [MI] TOFACITINIB [INN] TOFACITINIB [VANDF] TOFACITINIB [WHO-DD] SCHEMBL322753 GTPL5677 orb1300872 SCHEMBL29351183 HSDB 8311 EX-A205 UJLAWZDWDVHWOW-YPMHNXCESA-N GLXC-90307 BDBM50193995 EBC-11351 HY-40354R NSC782351 NSC800953 s2789 AKOS005145814 AKOS005258733 AC-8193 AT43433 CCG-264998 CS-0050 DB08895 FT32555 GS-6106 NSC-782351 NSC-800953 SDCCGSBI-0654407.P002 NCGC00229511-02 NCGC00229511-04 NCGC00229511-10 NCGC00229511-24 NCGC00229511-25 NCGC00244463-01 Tofacitinib (CP-690550, Tasocitinib) 3-[(3R*,4R*)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile HY-40354 NS00069315 CP- 690 550 D09970 AB01565786_02 EN300-1718468 AR-270/43507983 F050788 Q3530324 BRD-K31283835-001-01-9 BRD-K31283835-048-04-4 (3R,4R)-3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile (3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-|A-oxo-, (3R,4R)- 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile citrate 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]piperidin-1-yl}-3-oxo-propionitrile 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile 3-{4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile REL-3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE
Mostrar todos os 115 sinônimos 
